Germany · Delayed Price · Currency is EUR Faes Farma Statistics
Total Valuation
Faes Farma has a market cap or net worth of EUR 1.48 billion. The enterprise value is 1.45 billion.
| Market Cap | 1.48B |
| Enterprise Value | 1.45B |
Important Dates
The next estimated earnings date is Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | Jan 8, 2026 |
Share Statistics
| Current Share Class | 311.26M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.27% |
| Owned by Institutions (%) | 9.79% |
| Float | 235.51M |
Valuation Ratios
The trailing PE ratio is 14.07 and the forward PE ratio is 16.59.
| PE Ratio | 14.07 |
| Forward PE | 16.59 |
| PS Ratio | 2.59 |
| PB Ratio | 2.03 |
| P/TBV Ratio | 2.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 13.81 |
| EV / Sales | 2.54 |
| EV / EBITDA | 11.95 |
| EV / EBIT | 14.24 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.69 |
| Debt / FCF | n/a |
| Interest Coverage | 64.48 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 8.23% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 301,544 |
| Profits Per Employee | 55,479 |
| Employee Count | 1,775 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5.11M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.64% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +38.64% |
| 50-Day Moving Average | 4.43 |
| 200-Day Moving Average | 4.20 |
| Relative Strength Index (RSI) | 65.06 |
| Average Volume (20 Days) | 153 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Faes Farma had revenue of EUR 571.12 million and earned 105.08 million in profits. Earnings per share was 0.34.
| Revenue | 571.12M |
| Gross Profit | 366.19M |
| Operating Income | 101.89M |
| Pretax Income | 99.91M |
| Net Income | 105.08M |
| EBITDA | 118.18M |
| EBIT | 101.89M |
| Earnings Per Share (EPS) | 0.34 |
Balance Sheet
The company has 111.62 million in cash and 83.78 million in debt, giving a net cash position of 27.85 million.
| Cash & Cash Equivalents | 111.62M |
| Total Debt | 83.78M |
| Net Cash | 27.85M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 730.04M |
| Book Value Per Share | 2.34 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 64.12%, with operating and profit margins of 17.84% and 18.40%.
| Gross Margin | 64.12% |
| Operating Margin | 17.84% |
| Pretax Margin | 17.49% |
| Profit Margin | 18.40% |
| EBITDA Margin | 20.69% |
| EBIT Margin | 17.84% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 3.09%.
| Dividend Per Share | 0.14 |
| Dividend Yield | 3.09% |
| Dividend Growth (YoY) | 14.01% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 3.09% |
| Earnings Yield | 7.11% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 7, 2015. It was a forward split with a ratio of 1.02.
| Last Split Date | Apr 7, 2015 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |